Saruta Takao | Keio University Graduate School Of Medicine

スポンサーリンク

概要

関連著者

もっと見る

著作論文

A randomized, double-blind, four-arm parallel-group study of the efficacy and safety of azelnidipine and olmesartan medoxomil combination therapy compared with each monotherapy in Japanese patients with essential hypertension : the REZALT study
Effects of candesartan and amlodipine on cardiovascular events in hypertensive patients with chronic kidney disease : subanalysis of the CASE-J Study
Effects of Cardiac Complications on Cardiovascular Events in Japanese High-Risk Hypertensive Patients : Subanalysis of the CASE-J Trial
Relationship between the achieved blood pressure and the incidence of cardiovascular events in Japanese hypertensive patients with complications : a sub-analysis of the CASE-J trial
Role of diabetes and obesity in outcomes of the candesartan antihypertensive survival evaluation in Japan (CASE-J) trial
Effect of heart rate on the risk of developing metabolic syndrome
-0785-PREDICTION OF PROGRESSION OF STENOSIS IN REMAINING CORONARY VESSELS BASED ON ANALYSIS OF ONSET PATTERN AND CORONARY ANGIOGRAPHIC FINDINGS IN PATIENTS SITH ONE-VESSEL MYOCARDIAL INFARCTION
Association of PLA2G7 polymorphisms with carotid atherosclerosis in hypertensive Japanese
Impact of Left Ventricular Hypertrophy on the Time-Course of Renal Function in Hypertensive Patients : A Subanalysis of the CASE-J Trial
The Optimal Target Blood Pressure for Antihypertensive Treatment in Japanese Elderly Patients with High-Risk Hypertension : A Subanalysis of the Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) Trial
Development and Progression of Atherosclerotic Disease in Relation to Insulin Resistance and Hyperinsulinemia
Metabolic Syndrome and Cardiac Disease in Japanese Men : Applicability of the Concept of Metabolic Syndrome Defined by the National Cholesterol Education Program-Adult Treatment Panel III to Japanese Men-The Tanno and Sobetsu Study
Genetic Polymorphisms of L-Type Calcium Channel α1c and α1D Subunit Genes are Associated With Sensitivity to the Antihypertensive Effects of L-Type Dihydropyridine Calcium-Channel Blockers
Comparison of Nifedipine Retard with Angiotensin Converting Enzyme Inhibitors in Japanese Hypertensive Patients with Coronary Artery Disease : The Japan Multicenter Investigation for Cardiovascular Diseases-B (JMIC-B) Randomized Trial
Prevention and regression of hypertension : role of renal microvascular protection
Relation of hypertension and glucose tolerance impairment in elderly people to the development of arteriosclerosis : Investigation using pulse wave velocity
Antihypertensive Efficacy and Safety of Fixed-Dose Combination Therapy with Losartan plus Hydrochlorothiazide in Japanese Patients with Essential Hypertension
evidence-based practice guideline for the treatment of chronic kidney disease
Prevalence of anemia according to stage of chronic kidney disease in a large screening cohort of Japanese
Heart rate as a risk factor for developing chronic kidney disease : longitudinal analysis of a screened cohort
Validation of Longitudinal Peak Systolic Strain by Speckle Tracking Echocardiography With Visual Assessment and Myocardial Perfusion SPECT in Patients With Regional Asynergy
Impact of renal function on cardiovascular events in elderly hypertensive patients treated with efonidipine : Renal Subset Analysis of the Japanese Trial to Assess Optimal Systolic Blood Pressure in Elderly Hypertensive Patients (JATOS)
Confirmation of ALDH2 as a Major Locus of Drinking Behavior and of Its Variants Regulating Multiple Metabolic Phenotypes in a Japanese Population
Influence of Coronary Risk Factors on Coronary Events in Japanese High-Risk Hypertensive Patients : Primary and Secondary Prevention of Ischemic Heart Disease in a Subanalysis of the Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) Trial
Japan Renal Biopsy Registry : the first nationwide, web-based, and prospective registry system of renal biopsies in Japan
T-Type Ca Channel Blockade as a Determinant of Kidney Protection
How to use marginal structural models in randomized trials to estimate the natural direct and indirect effects of therapies mediated by causal intermediates

もっと見る

スポンサーリンク